scholarly journals Suppression of Hyperlipidemia-Associated Cataracts in Diabetic Rats with the Lipoprotein Lipase Activator NO-1886.

1996 ◽  
Vol 19 (12) ◽  
pp. 1570-1573 ◽  
Author(s):  
Kazuhiko TSUTSUMI ◽  
Yasuhide INOUE ◽  
Chieko YOSHIDA
Keyword(s):  
Lipoprotein Lipase ◽  
Diabetic Rats

Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids

1992 ◽  
Vol 70 (9) ◽  
pp. 1271-1279 ◽  
Author(s):  
Brian Rodrigues ◽  
Janice E. A. Braun ◽  
Michael Spooner ◽  
David L. Severson
Keyword(s):  
Lipoprotein Lipase ◽  
Cardiac Myocytes ◽  
Lipase Activity ◽  
Plasma Lipids ◽  
Inhibitory Effect ◽  
Diabetic Rats ◽  
Diabetic Rat ◽  
Lipoprotein Lipase Activity ◽  
Triton Wr 1339 ◽  
Plasma Triacylglycerol

The objective of this investigation was to test the hypothesis that the diabetes-induced reduction in lipoprotein lipase activity in cardiac myocytes may be due to hypertriglyceridemia. Administration of 4-aminopyrazolopyrimidine (50 mg/kg) to control rats for 24 h reduced plasma triacylglycerol levels and increased the heparin-induced release of lipoprotein lipase into the incubation medium of cardiac myocytes. The acute (3–5 days) induction of diabetes by streptozotocin (100 mg/kg) produced hypertriglyceridemia and reduced heparin-releasable lipoprotein lipase activity in cardiac myocytes. Treatment of diabetic rats with 4-aminopyrazolopyrimidine resulted in a fall in plasma triacylglycerol content and increased heparin-releasable lipoprotein lipase activity. Administration of Triton WR-1339 also resulted in hypertriglyceridemia, but the heparin-induced release of lipoprotein lipase from control cardiac myocytes was not reduced in the absence of lipolysis of triacylglycerol-rich lipoproteins. Treatment with Triton WR-1339 did, however, increase the heparin-induced release of lipoprotein lipase from diabetic cardiac myocytes. Preparation of cardiac myocytes with 0.9 mM oleic acid resulted in a decrease in both total cellular and heparin-releasable lipoprotein lipase activities. These results suggest that the diabetes-induced reduction in heart lipoprotein lipase activity may, at least in part, be due to an inhibitory effect of free fatty acids, derived either from lipoprotein degradation or from adipose tissue lipolysis, on lipoprotein lipase activity in (and (or) release from) cardiac myocytes.Key words: diabetes, plasma triacylglycerols, cardiac myocytes, lipoprotein lipase.

Oscillatory changes in muscle lipoprotein lipase activity of fed and starved rats.

1977 ◽  
Vol 233 (4) ◽  
pp. E316
Author(s):  
T J Kotlar ◽  
J Borensztajn
Keyword(s):  
Lipoprotein Lipase ◽  
Lipase Activity ◽  
Feeding Habits ◽  
Quadriceps Muscle ◽  
Diabetic Rats ◽  
Lipoprotein Lipase Activity ◽  
Nocturnal Feeding ◽  
Ad Libitum ◽  
Short Time ◽  
Fast Twitch

Lipoprotein lipase activity was measured at short time intervals in cardiac and skeletal muscles of normal and streptozotocin-treated diabetic rats fed ad libitum or deprived of food. In normal animals fed ad libitum, lipoprotein lipase activities of heart, diaphragm, soleus, and fast-twitch red fibers of the quadriceps muscle showed rhythmic oscillations that appeared to coincide with the nocturnal feeding habits of the animals. During the day (7 A.M. to 7 P.M.), when food consumption by the rats was greatly reduced, lipoprotein lipase activity in all muscles increased, followed by a decline to basal levels during the night. Similar oscillatory changes in lipoprotein lipase activity were observed in the muscles of diabetic rats fed ad libitum. In normal rats deprived of food, however, the oscillatory changes in muscle lipoprotein lipase activity were not abolished and persisted for at least 48 h. In diabetic rats starved during a 48-h period, the oscillatory changes in muscle lipoprotein lipase activity were markedly altered. In all animals, muscle lipoprotein lipase activities were not correlated to plasma glucagon levels.

Response of lipoprotein lipase to calorie intake in streptozotocin-induced diabetic rats

1992 ◽  
Vol 52 (8) ◽  
pp. 797-802 ◽  
Author(s):  
H. Inadera ◽  
J. Tashiro ◽  
Y. Okubo ◽  
Y. Ishikawa ◽  
K. Shirai ◽  
...  
Keyword(s):  
Lipoprotein Lipase ◽  
Diabetic Rats ◽  
Calorie Intake

Lipoprotein Lipase Activities in Heart Muscle of Streptozotocin-Induced Diabetic Rats

1984 ◽  
Vol 16 (02) ◽  
pp. 67-70 ◽  
Author(s):  
T. Nakai ◽  
K. Oida ◽  
T. Tamai ◽  
S. Yamada ◽  
T. Kobayashi ◽  
...  
Keyword(s):  
Lipoprotein Lipase ◽  
Heart Muscle ◽  
Diabetic Rats

Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes

1991 ◽  
Vol 260 (3) ◽  
pp. E477-E485 ◽  
Author(s):  
J. E. Braun ◽  
D. L. Severson
Keyword(s):  
Cell Surface ◽  
Phospholipase C ◽  
Lipoprotein Lipase ◽  
Cardiac Myocytes ◽  
Myocardial Cell ◽  
Diabetic Rats ◽  
Capillary Endothelium ◽  
Rat Hearts ◽  
Isolated Cardiac Myocytes ◽  
Covalently Linked

Incubation of isolated cardiac myocytes from rat hearts with heparin or phosphatidylinositol-specific phospholipase C (PLC) resulted in the release of lipoprotein lipase (LPL) into the medium. The release of LPL by the combination of heparin and PLC was not additive, and preincubation of cardiac myocytes with heparin eliminated the release of LPL in a subsequent incubation with PLC. This evidence suggests that LPL may be bound ionically to heparan sulfate proteoglycans that are covalently linked to the cell surface of cardiac myocytes by a phosphatidylinositol-glycan membrane anchor; a second pool of LPL may also be bound to proteoglycans attached directly to the myocardial cell surface. The induction of diabetes by the administration of streptozotocin (100 mg/kg for 3-4 days) to rats resulted in a decrease in the initial cellular activity of LPL and a marked reduction in the heparin-induced secretion of LPL into the medium of cardiac myocytes. The intravenous administration of insulin (5 U for 1 h) in diabetic rats reversed the effects of diabetes on cellular and heparin-releasable LPL activities. Diabetes also reduced the PLC-induced release of LPL. The reduction in the release of LPL from diabetic cardiac myocytes could result in a decrease in functional LPL activity at the capillary endothelium of whole hearts.

Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia

1995 ◽  
Vol 73 (3) ◽  
pp. 369-377 ◽  
Author(s):  
Limin Liu ◽  
David L. Severson
Keyword(s):  
Lipoprotein Lipase ◽  
Selective Reduction ◽  
Diabetic Rats ◽  
Diabetic Rat ◽  
Compensatory Response ◽  
Perfusion Solution ◽  
Rat Hearts ◽  
Perfused Hearts ◽  
Control Plasma ◽  
Sustained Increase

The decrease in myocardial lipoprotein lipase (LPL) activity observed previously in acute, severe models of insulin-deficient diabetes may be a compensatory response to hypertriglyceridemia and a sustained increase in fatty acid delivery to cardiomyocytes. The administration of fructose (10% solution in the drinking water for 4 days) to rats produced hypertriglyceridemia, but heparin-releasable LPL activity from perfused hearts and total and heparin-releasable LPL activities in isolated cardiomyocytes were not reduced. The acute (4 day) induction of a mild diabetic state (60 mg/kg streptozotocin) resulted in modest hypertriglyceridemia, and a selective decrease in heparin-releasable LPL activity in perfused hearts; LPL activity in cardiomyocytes from diabetic rat hearts was not reduced. Therefore, the diabetes-induced fall in myocardial LPL activity is not secondary to hypertriglyceridemia, since fructose treatment did not change LPL activity. Perfusion of rat hearts with 100 μM lysophosphatidylcholine (LPC) released a small amount of LPL activity into the perfusate, but only if albumin was omitted from the perfusion solution. Thus, the selective reduction in heparin-releasable LPL activity in perfused diabetic hearts is probably not the consequence of displacement by LPC, a lipolytic product of the LPL-catalyzed degradation of triacylglycerol-rich lipoproteins. Circulating LPL activity in the plasma of diabetic rats was not decreased relative to control plasma enzyme activity; therefore, the reduction in heparin-releasable LPL activity is not because circulating LPL was less available for uptake by the endothelium in diabetic hearts.Key words: diabetes, lipoprotein lipase, perfused hearts, cardiomyocytes.

Sign in / Sign up

Export Citation Format

Share Document